EPISODE · Nov 4, 2011 · 22 MIN
Podcast 136: Aspirin lowers colorectal risks in Lynch syndrome — what are the implications for everyone else?
from Clinical Conversations · host NEJM Group
Last week’s Lancet article on the effect of aspirin on risks for colorectal cancer in patients with Lynch syndrome — a group at particularly high risk — may hold implications for preventing sporadic colon cancers. Our interview with Prof. Sir John Burn, the study’s first author, explores those implications as well speculations on why we human beings aren’t getting the salicylates we were when our vegetables weren’t so pampered. Links: Physician’s First Watch coverge (free) Lancet abstract (free) NEJM 2008 paper (free) The CAPP3 website The post Podcast 136: Aspirin lowers colorectal risks in Lynch syndrome — what are the implications for everyone else? first appeared on Clinical Conversations.
Embed this episode
What this episode covers
Last week’s Lancet article on the effect of aspirin on risks for colorectal cancer in patients with Lynch syndrome — a group at particularly high risk — may hold implications for preventing sporadic colon cancers. Our interview with Prof. Sir John Burn, the study’s first author, explores those implications as well speculations on why we human […]
NOW PLAYING
Podcast 136: Aspirin lowers colorectal risks in Lynch syndrome — what are the implications for everyone else?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.